Aura Biosciences to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Feb 25, 2025
BOSTON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences:
Read more at globenewswire.com
